Gemmer Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-108
Closed -$9K – 1029
2022
Q1
$9K Hold
108
– – ﹤0.01% 759
2021
Q4
$9K Hold
108
– – ﹤0.01% 793
2021
Q3
$7K Hold
108
– – ﹤0.01% 856
2021
Q2
$7K Hold
108
– – ﹤0.01% 975
2021
Q1
$6K Hold
108
– – ﹤0.01% 1008
2020
Q4
$4K Hold
108
– – ﹤0.01% 1120
2020
Q3
$3K Buy
108
+6
+6% +$153 ﹤0.01% 1108
2020
Q2
$2K Buy
+102
New +$2.01K ﹤0.01% 1206
2020
Q1
– Sell
-223
Closed -$8K – 1435
2019
Q4
$8K Hold
223
– – ﹤0.01% 757
2019
Q3
$5K Buy
+223
New +$4.75K ﹤0.01% 985
2019
Q2
– Sell
-79
Closed -$2K – 1435
2019
Q1
$2K Buy
+79
New +$1.95K ﹤0.01% 1290
2016
Q3
– Sell
-93
Closed -$3K – 1256
2016
Q2
$3K Buy
+93
New +$2.75K ﹤0.01% 1083
2015
Q4
– Sell
-71
Closed -$3K – 1294
2015
Q3
$3K Hold
71
– – ﹤0.01% 1007
2015
Q2
$4K Hold
71
– – ﹤0.01% 945
2015
Q1
$4K Hold
71
– – ﹤0.01% 987
2014
Q4
$4K Hold
71
– – ﹤0.01% 964
2014
Q3
$4K Hold
71
– – ﹤0.01% 972
2014
Q2
$3K Hold
71
– – ﹤0.01% 1093
2014
Q1
$3K Buy
+71
New +$3.13K ﹤0.01% 1075

Other funds holding THC

Gemmer Asset Management's THC Position: Q2 2022 in Review

Gemmer Asset Management sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 108 shares — an estimated $9K sold.

Gemmer Asset Management first reported a position in THC in Q1 2014 and held it in 19 quarters. The position peaked at $9K in Q1 2022. 371 funds tracked by Wall St. Rank hold THC as of Q2 2022.

  • Gemmer Asset Management reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 108 Tenet Healthcare shares in Q2 2022, an estimated $9K.
  • Gemmer Asset Management first reported a position in Tenet Healthcare in Q1 2014 and held it in 19 quarters.
  • Gemmer Asset Management's Tenet Healthcare position peaked at $9K in Q1 2022.
  • 371 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.